Last updated on: 5/28/2009 | Author: ProCon.org

Camille B. Carroll, PhD Biography

Title:
Clinical Research Fellow at the Peninsula College of Medicine & Dentistry
Position:
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“Seventeen patients completed the RCT (randomized placebo-controlled crossover study). Cannabis was well tolerated, and had no pro- or antiparkinsonian action. There was no evidence for a treatment effect on levodopa-induced dyskinesia as assessed by the UPDRS [Unified Parkinson Disease Rating Scale], or any of the secondary outcome measures.

Conclusions: Orally administered cannabis extract resulted in no objective or subjective improvement in dyskinesias or parkinsonism.”

“Cannabis For Dyskinesia In Parkinson Disease: A Randomized Double-blind Crossover Study,” Neurology, 2004
Theoretical Expertise Ranking:
    Experts
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
Involvement and Affiliations:
  • Clinical Research Fellow at the Peninsula College of Medicine & Dentistry
  • Department of Neurology, Derriford Hospital, Plymouth, United Kingdom
  • Member of the Royal College of Physicians (MRCP)
Education:
  • PhD, school unknown
Other:
  • None found